ASTH

ASTH Deferred Revenue

$0.00Quarterly · USD

Period ending:

ASTH FY Deferred RevenueUSD
ASTH FY Deferred Revenue2016-03-31: $110.65K2017-12-31: $250.00K2018-12-31: $9.02M2019-12-31: $8.89M2020-12-31: $12.99M2021-12-31: $16.80M2022-12-31: $531.00K2023-12-31: $744.00K2024-12-31: $1.61M2025-12-31: $2.66M$16.80M$0.00
2016-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ASTH deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 10 observations from Mar 31, 2016 to Dec 31, 2025.

Astrana Health Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
2,659,000
1,606,000
744,000
531,000
16,798,000
12,988,000
8,892,000
9,024,235
250,000
110,654

Compare deferred revenue

All ASTH financial metrics · ASTH stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.